Valiant(SZ:002643)2022-12-06 11:11Group 1: Company Overview - The company has restructured its business segments from four to three: Information Materials Industry, Environmental Industry, and Health Industry [4] - In Q1 2016, the company's revenue increased by 59.17% year-on-year, and net profit attributable to shareholders grew by 279.62% due to increased orders, higher production, lower unit costs, and increased gross profit [4] Group 2: Business Developments - The production workshop for zeolite series environmental materials for Euro VI standard exhaust treatment has been completed and is in operation [5] - The company completed the acquisition of 100% equity in MP Company on March 18, 2016, which will play a significant role in expanding the health industry product line [5] Group 3: Research and Development - The company has over 200 R&D personnel and more than 400 technical staff, focusing on new product development and process improvement for existing products [5] - The R&D efforts are aimed at developing products with strong market potential, such as liquid crystal materials, zeolite series environmental materials, and OLED materials [5] Group 4: Investor Relations - The investor relations activity took place on May 11, 2016, with various investment firms and analysts participating [2][3] - The company ensured compliance with relevant regulations during the investor meeting, with no significant information leakage [6]